NMSO Spółka z Ograniczoną Odpowiedzialnością (KRS 0000747278, NIP 5833320636) is a Polish company, headquartered in Gdańsk, Pomorskie voivodeship. NMSO operates in: Specialist medical practice activities (PKD 86.22.Z). Industry: Healthcare. The company has been listed in the National Court Register since September 4, 2018. NMSO's most recently reported net revenue was 0 PLN for 2022.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - NMSO
Identity
- Name
- NMSO Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- September 4, 2018
- Registry status as of
- November 21, 2025
- Latest entry
- September 2, 2025
- Founding act
- 25.08.2018
Articles of association history (2)
- August 25, 2018: 25.08.2018
- January 26, 2021: 26.01.2021 R., REPERTORIUM A NR 328/2021, NOTARIUSZ KALINA BARTECKA KANCELARIA NOTARIALNA, UL. LEGIONÓW 116A/4, 81-472 GDYNIA ZMIANA §2, §15
Activities
Main activity
86.22.ZSpecialist medical practice activities
Other activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- UL. DYWIZJI WOŁYŃSKIEJ, 85, 80-041, GDAŃSK, POLSKA
- Voivodeship
- POMORSKIE
- District
- GDAŃSK
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
- Coordinates
- 54.3598, 18.6360approx.
Risk and payment profile - NMSO
Credibility rating
50.8 / 100
Average credibility
Insolvency risk
Very low
Low threat
Closure risk
6
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
3
3/8 yrs
Board changes
1
1/8 yrs
PKD changes
0
0/8 yrs
Name changes
1
1/8 yrs
Data from 8 years of registry activity.
Credibility history
Payment reliability score from 2019–2022
Current: D (51/100)
Trend: improving (+19.2 pts/year)
Słaba wiarygodność płatnicza – wskaźniki finansowe sugerują podwyższone ryzyko opóźnień lub niewykonania zobowiązań.
Trade credit limit history
Standard limit from 2019–2022
Current: 0 PLN
Safe: 0 PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - NMSO
Founded
September 4, 2018
7 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
GDAŃSK
POMORSKIE
Primary PKD
86.22.Z
Specialist medical practice activities
Share capital
5.0 K PLN
100 shares total
Shareholders
3
shareholders
Board
1 person
Filed years
3 years
2019–2022 · profitable: 0/3
Registry entries
21
latest: September 2, 2025
Revenue
0 PLN
2022
Net profit
N/A
2022
Assets
64.0 K PLN
2022
Equity
N/A
2022
EBITDA
N/A
2022
no depreciation data
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - NMSO.
No ratings
Related articles
News
Longevity Center launches Longevity Academy: Poland's first accredited longevity-medicine educational programme for doctors
Warsaw-based Longevity Center sp. z o.o. (KRS 0000796083, ul. Belwederska 9) has launched Longevity Academy - one of the first in the world and the first in Poland accredited longevity-medicine educational programme for doctors. Accreditation by the Polish Medical Chamber; scientific partner: the Buck Institute for Research on Aging in California. The programme is built on 6+ years of clinical practice and 3,000+ patients.
Explainer
Voxel in 2026: a Kraków operator of medical-imaging centres and radiopharmaceuticals, an mWIG40 issuer with a two-member management board
Voxel S.A. (KRS 0000238176), headquartered at ul. Wielicka 265 in Kraków, is a Polish operator of medical-imaging centre networks (MRI, CT, X-ray, ultrasound, mammography) and a radiopharmaceutical producer. The company was founded in 2005, listed on the WSE since 2011. It operates under the Voxel-Diagnostic brand at several dozen locations across Poland. A two-member management board, a five-member supervisory board.
